- Skin Lesions and Treatment With Tumor Necrosis Factor Alpha ...🔍
- Tumour necrosis factor inhibitor|induced myositis in a patient with ...🔍
- Successful Treatment of Dermatomyositis and Polymyositis with Anti ...🔍
- Evaluating safety and compatibility of anti|tumor necrosis factor ...🔍
- Cutaneous dermatomyositis in the era of biologicals🔍
- Tumor Necrosis Factor|α Inhibitor Associated Ulcerative Colitis🔍
- Management of refractory cutaneous dermatomyositis in adults🔍
- Environmental triggers of dermatomyositis🔍
Tumor Necrosis Factor Inhibitor–Associated Dermatomyositis
Skin Lesions and Treatment With Tumor Necrosis Factor Alpha ...
Most of these reactions are mild to moderate without requiring, in most cases, the withdrawal of the drug. The type of associated skin reactions can be very ...
Tumour necrosis factor inhibitor-induced myositis in a patient with ...
Tumor necrosis factor inhibitor-associated dermatomyositis. Arch. Dermatol. 2010;146(7):780–784. [13] Ishikawa Y, Yukawa N, Ohmura K, et al. Etanercept ...
Successful Treatment of Dermatomyositis and Polymyositis with Anti ...
... TNF inhibitors (Infliximab, Adalimumab and Etanercept) have been approved to treat autoimmune disorders including rheumatoid arthritis (RA), juvenile ...
Evaluating safety and compatibility of anti-tumor necrosis factor ...
Anti-TNFα therapy often induces the formation of autoantibodies against nuclear antigens (ANAs) which are associated with a variety of primary autoimmune ...
Cutaneous dermatomyositis in the era of biologicals
The advent of biological agents including tumor necrosis factor-α antagonists ... Tumor necrosis factor inhibitor-associated dermatomyositis. R. KleinM ...
Tumor Necrosis Factor-α Inhibitor Associated Ulcerative Colitis
The female patient had amyopathic dermatomyositis. Two of the 4 patients had ulcerative colitis prior to tumor necrosis factor-α treatment. Both of these ...
Management of refractory cutaneous dermatomyositis in adults
RELATED TOPICS. Calcinosis cutis: Management · Clinical manifestations of dermatomyositis and polymyositis ... Tumor necrosis factor-alpha ...
Environmental triggers of dermatomyositis: a narrative review - Bax
Although TNF-α inhibitors have been tested as potential therapies to treat DM, results have been mixed with many patients experiencing worsening of their ...
(PDF) Tumor Necrosis Factor Inhibitor–Associated
Tumor Necrosis Factor Inhibitor–Associated Dermatomyositis by Rachel Klein, Misha Rosenbach, Ellen J. Kim, Brian Kim, Victoria P. Werth, ...
Expression of tumor necrosis factor-like weak inducer of apoptosis ...
The aim of this study was to investigate the expression of tumor necrosis factor-like weak inducer of apoptosis (TWEAK) and its receptor ...
Possible role for tumour necrosis factor inhibitors in the treatment of ...
The utility of tumour necrosis factor blockade in orphan diseases. E C Keystone, · 2004 ; Cyclosporin A and intravenous immunoglobulin treatment ...
Treatment of Dermatomyositis and Polymyositis with Anti-Tumor ...
... 68 The clinical use of TNF-blocking reagents in inflammatory myopathies has been limited to case reports and small case series. [69][70] [71] [72][73][74][ ...
Concurrence of dermatomyositis and psoriasis: a case report and ...
And while TNF-α inhibitors may be a potential therapy for DM, the worsening of the disease can also be seen during treatment (29). Further observation is ...
Possible role for tumour necrosis factor inhibitors in the treatment of ...
Abstract: Anti-TNF agents may be useful in some patients with refractory dermatomyositis or polymyositis. · Trusted by researchers and organizations around the ...
Dermatomyositis: Practice Essentials, Background, Pathophysiology
One report has linked tumor necrosis factor (TNF) abnormalities with dermatomyositis. ... Tumor necrosis factor inhibitors. Programmed ...
Development of anti-MDA5 autoantibody-positive dermatomyositis ...
Tumour necrosis factor (TNF) inhibitors (TNFi) change the clinical course of rheumatoid arthritis (RA) by reducing synovial inflammation and ...
New-onset of medication-associated dermatomyositis in a patient ...
A diagnosis of DM, most likely induced by TNF-α inhibitor, was made. • Adalimumab was switched to tofacitinib XR 11mg daily and hydroxychloroquine (HCQ) at 5mg/ ...
Juvenile Dermatomyositis - Journal of Rheumatic Diseases
Reports of the use of other biological agents such as tumor necrosis factor (TNF)-α inhibitors, abatacept, tofacitinib are based on case reports ...
Possible role for tumour necrosis factor inhibitors in the treatment of ...
RESULTS: 8 patients with dermatomyositis or polymyositis who were treated with TNF inhibitors as adjunct treatment were identified. The mean (SD) ...
Is dermatomyositis in patients with rheumatoid arthritis induced by ...
Many cases of myopathies associated with anti-TNF-α therapies can be found in the literature, two cases of PM associated with infliximab, one ...